Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Green Landscaping Group | GREEN | Nov 4, 2024 | 76.70 | -1.54 |
Greenmerc | GMERCB | Nov 4, 2024 | 5.70 | -11.76 |
Gruvaktiebolaget Viscaria | VISC | Nov 4, 2024 | 20.05 | -1.23 |
Gränges | GRNG | Nov 4, 2024 | 123.50 | -0.40 |
Grängesberg Exploration Holding | GRANGX | Nov 4, 2024 | 10.86 | +12.42 |
Guard Therapeutics International | GUARD | Nov 4, 2024 | 24.60 | -3.15 |
Guideline Geo | GGEO | Nov 4, 2024 | 8.16 | -2.63 |
Gullberg & Jansson | GJAB | Nov 4, 2024 | 19.75 | -1.25 |
H&D Wireless Sweden Holding B | HDWB | Nov 4, 2024 | 0.00 | -2.56 |
H&M B | HMB | Nov 4, 2024 | 162.00 | +1.57 |
HAKI Safety A | HAKIA | Nov 4, 2024 | 29.80 | 0.00 |
HAKI Safety B | HAKIB | Nov 4, 2024 | 28.00 | -0.71 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 4, 2024 | 3.65 | +13.71 |
Hansa Biopharma | HNSA | Nov 4, 2024 | 35.04 | -4.47 |
Hanza AB | HANZA | Nov 4, 2024 | 69.65 | +0.29 |
Harm Reduction Group | NOHARM | Nov 4, 2024 | 0.07 | -1.91 |
Havsfrun Investment | HAVS | Nov 4, 2024 | 12.20 | -1.21 |
Havsfrun Investment B | HAVB | Nov 4, 2024 | 12.20 | -1.21 |
Haypp Group | HAYPP | Nov 4, 2024 | 73.40 | +0.55 |
Headsent | VIMAB | Nov 4, 2024 | 12.50 | 0.00 |
Heba B | HEBAB | Nov 4, 2024 | 32.60 | -1.21 |
Hedera Group | HEGR | Nov 4, 2024 | 3.38 | 0.00 |
Heimstaden Pref | HEIMPREF | Nov 4, 2024 | 16.92 | -1.51 |
Heliospectra | HELIO | Nov 4, 2024 | 0.58 | -3.34 |
Hemnet Group | HEM | Nov 4, 2024 | 323.60 | -0.98 |
Hemply Balance | HMPLY | Nov 4, 2024 | 0.05 | +11.90 |
Hernö Gin B | HERNOB | Nov 4, 2024 | 3.95 | -0.63 |
Hexagon B | HEXAB | Nov 4, 2024 | 100.75 | -0.89 |
Hexagon Purus | HPURO | Nov 4, 2024 | 6.36 | -4.50 |
Hexatronic Group | HTRO | Nov 4, 2024 | 43.30 | -0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.